Kinder Morgan Inc vs Nuwellis Inc — how do they compare? Kinder Morgan Inc trades at $32.47 (market cap $72.48B), while Nuwellis Inc trades at $2.84 (market cap $1.09M). The key difference: Kinder Morgan Inc is far larger — about 66495.4× Nuwellis Inc's market cap, and Kinder Morgan Inc pays a 3.61% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| KMI | NUWE | |
|---|---|---|
Market Cap | $72.48B | $1.09M |
Sector | Energy | Technology |
52-Week High | $34.31 | $527.46 |
52-Week Low | $25.84 | $2.80 |
Enterprise Value | $104.36B | -$722.58K |
Dividend Yield | 3.61% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
Trailing returns across standard periods
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →